Conavi Medical Corp.

Conavi Medical Corp.

0.08
USD
0.00
(0.00%)
-0.16EPS
17.06MMarket Cap
Dec 17Next Earn

Total Valuation

USD

As of June 30, 2026, Conavi Medical Corp. carries a market capitalization of 17.06M, placing it among publicly traded companies globally. Its enterprise value stands at 29.12M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap17.06M
Enterprise Value29.12M

Important Dates

Conavi Medical Corp.'s next confirmed earnings release is scheduled for December 17, 2026.

Earnings Date12/17/2026

Share Statistics

As of June 30, 2026, Conavi Medical Corp. has 103.49M shares outstanding.

Shares Outstanding103.49M

Valuation Ratios

These figures are as of June 30, 2026. The price-to-sales ratio is 24.70, and the price-to-book ratio stands at -1.24.

PS Ratio24.70
PB Ratio-1.24
P/TBV Ratio-1.12
P/FCF Ratio-1.08
P/OCF Ratio-1.12

Enterprise Valuation

These figures are as of June 30, 2026. The EV/Sales ratio of 48.90 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 29.12M versus a market cap of 17.06M, with the gap driven by net debt and cash on the balance sheet.

EV / Sales48.90

Financial Position

As of June 30, 2026, Conavi Medical Corp. maintains a current ratio of 0.21, meaning it holds 0.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -92.18, indicating conservative leverage, while an interest coverage ratio of -22.30 demonstrates limited ability to service its debt obligations.

Current Ratio0.21
Quick Ratio0.18
Debt / Equity-92.18
Debt / EBITDA-0.88
Interest Coverage-22.30

Financial Efficiency

USD

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -155.50, reflecting losses generated across the asset base. The company generates approximately 12,943.51 in revenue per employee across its workforce of 46.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 0.29 indicates how many times Conavi Medical Corp. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Assets (ROA)-155.50
Revenue Per Employee12,943.51
Employee Count46.00
Inventory Turnover0.29

Stock Price Statistics

USD

As of the close on November 16, 2026, Conavi Medical Corp.'s stock has declined approximately 82.64% over the past 52 weeks. The 50-day moving average sits at 0.10, while the 200-day moving average is 0.20.

52-Week Price Change-82.64%
50-Day Moving Average0.10
200-Day Moving Average0.20

Income Statement

USD

Over the twelve months ended June 30, 2026, Conavi Medical Corp. generated 595,401.67 in revenue and converted that into -14.53M in net income, yielding earnings per share of -0.16. EBITDA reached -14.34M, while operating income came in at -14.94M.

Revenue595,401.67
Gross Profit572,149.29
Operating Income-14.94M
Pretax Income-14.53M
Net Income-14.53M
EBITDA-14.34M
EBIT-14.94M
Earnings Per Share (EPS)-0.16

Balance Sheet

USD

As of June 30, 2026, Conavi Medical Corp. holds 622,881.74 in cash and equivalents against 12.68M in total debt, resulting in a net debt position of 11.55M. Total book value stands at -13.76M, with working capital of -12.74M providing operational flexibility.

Cash & Cash Equivalents622,881.74
Total Debt12.68M
Net Debt11.55M
Equity (Book Value)-13.76M
Book Value Per Share-0.13
Working Capital-12.74M

Cash Flow

USD

Conavi Medical Corp. produced -13.15M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -516,484.52 in capital expenditures, free cash flow totaled -13.66M - equivalent to -0.15 per share.

Operating Cash Flow-13.15M
Capital Expenditures-516,484.52
Free Cash Flow-13.66M
FCF Per Share-0.15

Margins

Over the twelve months ended June 30, 2026, Conavi Medical Corp. posted a gross margin of 96.09, reflecting its pricing power and cost economics. The operating margin of -2,508.99 and net profit margin of -2,439.76 provide insight into operational efficiency.

Gross Margin96.09
Operating Margin-2,508.99
Pretax Margin-2,439.76
Profit Margin-2,439.76
EBITDA Margin-2,408.99

Dividends & Yields

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -92.93: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -37.15, meaning Conavi Medical Corp. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-37.15
FCF Yield-92.93

Stock Splits

Conavi Medical Corp.'s most recent stock split took place on October 16, 2024 with a 25:1 split ratio.

Last Split Date10/16/2024
Split Ratio25:1

Scores

As of June 30, 2026, Conavi Medical Corp. has an Altman Z-Score of -50.87, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-50.87